文献速递冠心病

中国资源受限医院急性冠脉综合征质量改进干预随机试验

Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China: A Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2019-01-01

IMPORTANCE: Prior observational studies suggest that quality of care improvement (QCI) initiatives can improve the clinical outcomes of acute coronary syndrome (ACS). To our knowledge, this has never been demonstrated in a well-powered randomized clinical trial.…

要点

  • 多层面质量改进干预未显著降低资源受限医院ACS患者院内MACE发生率。
  • 干预显著改善复合KPI评分及7项关键绩效指标,包括早期抗血小板治疗和出院二级预防药物使用。
  • 在非PCI医院推广质量改进干预需关注流程指标与临床结局之间的转化差距。

核心结论

  • 在资源受限的中国医院中,多层面质量改进干预对院内MACE无显著影响,但改善了部分循证ACS管理的过程指标。

主要发现

  • 干预显著提高复合KPI评分(均值[SD] 0.69[0.22] vs 0.61[0.23],P<.01)及7项个体KPI,包括早期使用抗血小板治疗和出院时适当使用二级预防药物。
  • 未报告非预期不良事件。

关键数值与推荐

  • 主要结局为院内MACE,包括全因死亡、再发心肌梗死/心肌梗死和非致死性卒中。
  • 次要结局包括16项关键绩效指标(KPI)及其复合评分。

临床怎么用

  • 在资源受限医院实施基于临床路径的多层面质量改进干预可改善ACS过程指标,但未显著改善院内MACE,临床应关注过程指标改善向结局转化的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Prior observational studies suggest that quality of care improvement (QCI) initiatives can improve the clinical outcomes of acute coronary syndrome (ACS). To our knowledge, this has never been demonstrated in a well-powered randomized clinical trial. OBJECTIVE: To determine whether a clinical pathway-based, multifaceted QCI intervention could improve clinical outcomes among patients with ACS in resource-constrained hospitals in China. DESIGN, SETTING, PARTICIPANTS: This large, stepped-wedge cluster randomized clinical trial was conducted in nonpercutaneous coronary intervention hospitals across China and included all patients older than 18 years and with a final diagnosis of ACS who were recruited consecutively between October 2011 and December 2014. We excluded patients who died before or within 10 minutes of hospital arrival. We recruited 5768 and 0 eligible patients for the control and intervention groups, respectively, in step 1, 4326 and 1365 in step 2, 3278 and 3059 in step 3, 1419 and 4468 in step 4, and 0 and 5645 in step 5. INTERVENTIONS: The intervention included establishing a QCI team, training clinical staff, implementing ACS clinical pathways, sequential site performance assessment and feedback, online technical support, and patient education. The usual care was the control that was compared. MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of in-hospital major adverse cardiovascular events (MACE), comprising all-cause mortality, reinfarction/myocardial infarction, and nonfatal stroke. Secondary outcomes included 16 key performance indicators (KPIs) and the composite score developed from these KPIs. RESULTS: Of 29 346 patients (17 639 men [61%]; mean [SD] age for control, 64.1 [11.6] years; mean [SD] age for intervention, 63.9 [11.7] years) who were recruited from 101 hospitals, 14 809 (50.5%) were in the control period and 14 537 (49.5%) were in the intervention period. There was no significant difference in the incidence of in-hospital MACE between the intervention and control periods after adjusting for cluster and time effects (3.9% vs 4.4%; odds ratio, 0.93; 95% CI, 0.75-1.15; P = .52). The intervention showed a significant improvement in the composite KPI score (mean [SD], 0.69 [0.22] vs 0.61 [0.23]; P < .01) and in 7 individual KPIs, including the early use of antiplatelet therapy and the use of appropriate secondary prevention medicines at discharge. No unexpected adverse events were reported. CONCLUSIONS AND RELEVANCE: Among resource-constrained Chinese hospitals, introducing a multifaceted QCI intervention had no significant effect on in-hospital MACE, although it improved a few of the care process indicators of evidence-based ACS management. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01398228.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Wu Y, Li S, Patel A, et al. Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China: A Randomized Clinical Trial. JAMA Cardiol. 2019. PMID: 30994898. doi:10.1001/jamacardio.2019.0897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。